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Abstract
Background: Burkholderia pseudomallei is a human pathogen causing severe infections in tropical and subtropical
regions and is classified as a bio-threat agent. B. thailandensis strain E264 has been proposed as less pathogenic
surrogate for understanding the interactions of B. pseudomallei with host cells.
Results: We show that, unlike B. thailandensis strain E264, the pattern of growth of B. thailandensis strain E555 in
macrophages is similar to that of B. pseudomallei. We have genome sequenced B. thailandensis strain E555 and
using the annotated sequence identified genes and proteins up-regulated during infection. Changes in gene
expression identified more of the known B. pseudomallei virulence factors than changes in protein levels and used
together we identified 16% of the currently known B. pseudomallei virulence factors. These findings demonstrate
the utility of B. thailandensis strain E555 to study virulence of B. pseudomallei.
Conclusions: A weakness of studies using B. thailandensis as a surrogate for B. pseudomallei is that the strains used
replicate at a slower rate in infected cells. We show that the pattern of growth of B. thailandensis strain E555 in
macrophages closely mirrors that of B. pseudomallei. Using this infection model we have shown that virulence
factors of B. pseudomallei can be identified as genes or proteins whose expression is elevated on the infection of
macrophages. This finding confirms the utility of B. thailandensis strain E555 as a surrogate for B. pseudomallei and
this strain should be used for future studies on virulence mechanisms.
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Background
The bacterial pathogen Burkholderia pseudomallei
causes meliodosis, a severe disease of humans in tropical
and subtropical regions [1–3]. The clinical manifesta-
tions of melioidosis range from an acute sepsis to
chronic localised disease to latent infection, which can
reactivate decades later from an as yet unknown tissue
reservoir [4, 5]. Community-acquired disease is most
likely a consequence of the bacterium in soil or water
entering through cuts or skin abrasions. In small animal
models of disease, the bacterium is much more infective
by the airborne or intranasal routes [6, 7]. This might be
consistent with the reported cases of disease in appar-
ently healthy US helicopter crew during the Vietnam
War, as a consequence of the inhalation of soil-derived
dusts containing bacteria [8]. The bacterium is consid-
ered a bio-threat agent because of the high infectivity by
the airborne route [2, 9]. A recent study has estimated
that worldwide there are 165,000 human melioidosis
cases and 89,000 deaths per year [1]. There is no li-
censed vaccine for the prevention of disease [10], and
the bacterium is inherently resistant to many antibiotics
[2, 11]. Against this background, there is an urgent need
for medical countermeasures to the disease, and the
development of new approaches to disease control will
be dependent on an understanding of the mechanisms
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by which B. pseudomallei establishes infection. Whilst a
range of studies have characterized some of the viru-
lence factors of B. pseudomallei [2, 12–14], it is also
clear that a much broader range of genes and proteins
are implicated in playing a role in disease [13, 15, 16].
However, studies on virulence of the bacterium are
necessarily constrained by the requirement to handle the
bacterium under containment level 3 conditions.
Burkholderia thailandensis is a close relative of B.
pseudomallei and is also found in the soil in tropical re-
gions of the world [17]. The genomes of B. pseudomallei
and B. thailandensis are very similar with two highly
syntenic chromosomes, which have similar numbers of
coding regions, similar assignments of encoded proteins
to families and similar numbers of horizontally acquired
genomic islands [18]. However, infections of humans
with B. thailandensis are rare and the bacterium can be
handled outside of a high containment laboratory.
Several previous studies have used B. thailandensis as a
surrogate for B. pseudomallei, to study virulence mecha-
nisms [19–37]. These studies have used B. thailandensis
isolates, such as strain E264, that replicate more slowly
than B. pseudomallei in cell cultures [38, 39]. These
strains lack the capsular polysaccharide of B. pseudomal-
lei, which is a key virulence determinant [14, 40].
However, a minority of B. thailandensis strains possess a
B. pseudomallei-like capsule [21, 40], though they are
not virulent in murine models of disease [40]. In this
study we set out to assess one of these strains as a surro-
gate for B. pseudomallei, in the hope that this would
more faithfully mimic the behavior of B. pseudomallei in
cell culture, and could be used to study virulence.
Results
Genome sequencing
We selected B. thailandensis strain E555 (a natural iso-
late previously described by Sim et al. [40]) for our study
because, unlike most B. thailandensis strains, it pos-
sesses a capsular polysaccharide which is similar to B.
pseudomallei [40, 41]. We sequenced the B. thailanden-
sis strain E555 available in our laboratory. Sequence data
are available at DDBJ/ENA/GenBank under the acces-
sion SJET00000000. In B. pseudomallei, the wcb operon,
which includes capsular polysaccharide genes, consists
of 20 genes (wcbA-T [42, 43]) of which 19 are also
encoded in the B. thailandensis strain E555 genome
(wcbN is not present) (Additional file 3: Table S1 C). In
addition to the capsule, B. thailandensis strain E555 has
been shown to exhibit several B. pseudomallei-like phe-
notypes such as colony wrinkling, resistance to human
complement binding, and survival in macrophages [40].
However, despite these similarities, B. thailandensis
strain E555 shows the same level of virulence in mice as
other B. thailandensis strains [40]. Using RAST [44] we
predicted 6508 open reading frames in our B. thailan-
densis strain E555 genome sequence data (ORFs;
Additional file 3: Table S1 A and B). We compared the
amino acid sequences of B. pseudomallei strain K96243
proteins to B. thailandensis strain E555 and B. thailan-
densis strain E264 and found 4535 proteins in both B.
thailandensis strain E555 and strain E264, 94 only in B.
thailandensis strain E555 and 380 only in B. thailanden-
sis strain E264. The remaining 914 proteins were not
found in either B. thailandensis strain and of these 233
were encoded by genes located in the genome islands in
B. pseudomallei.
Infection model
We first infected J774A.1 mouse macrophage cells with
B. thailandensis strain E555 and the number of intracel-
lular bacteria was measured at intervals. We compared
this data with data previously obtained in our laboratory
using an identical method with B. pseudomallei strain
K96243 or B. thailandensis strain E264 which is
commonly used as a surrogate for B. pseudomallei [39].
B. thailandensis strain E555 and B. pseudomallei strain
K96243 had similar growth rates in macrophages
(doubling times are 2.02 h for B. pseudomallei strain
K96243 and 2.06 h for B. thailandensis strain E555 over
the 4 h period between 4 h and 8 h post-infection), while
the growth of B. thailandensis strain E264 was slower
and showed a different growth pattern (p values between
B. pseudomallei strain K96243 and B. thailandensis
strain E264 were p < 0.001 at 4 h, 6 h and 8 h
post-infection, see Fig. 1).
Analysis of the global bacterial transcriptome
To investigate how B. thailandensis strain E555 adapts
to the intracellular environment in J774A.1 mouse
macrophage cells, the transcriptional and translational
landscapes of the bacteria were profiled, using RNA-seq
or mass spectrometry, after overnight growth in broth
culture and during macrophage infection. Nine genes
(Additional file 4: Table S2) were selected to validate the
data generated from the RNA-seq study using RT-qPCR
(the 23S rRNA was used as an internal control) [45, 46]
(Fig. 2).
We identified broadly similar numbers of genes
expressed in broth-cultured bacteria (n = 5071) or in
bacteria from macrophages (n = 4378 and n = 5112 at 5
and 6 h post-infection) and most (n = 3893) were
expressed in all 3 samples (Fig. 3 a and Additional file 5:
Table S3). The abundance of transcripts at 5 h or 6 h
post-infection (Fig. 3 a) showed a high correlation (R =
0.904; Additional file 1: Figure S1). Unique transcripts
were more abundant at 6 h (n = 329) than at 5 h (n = 91)
post-infection indicating that the adaptation of the
bacteria to the intracellular environment was still in
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progress between 5 h and 6 h post-infection. Expression
of all of the wcb genes (n = 19) encoded in the B. thai-
landensis strain E555 genome was detected in the
transcriptomes of bacteria grown in broth and bacteria
grown in macrophages (at 5 h and 6 h post-infection)
(Additional file 7: Table S5.F). Overall, we concluded
that the RNA-seq analysis provided a robust picture of
the B. thailandensis transcriptome.
Analysis of the global bacterial proteome
For proteomics, we used an immunomagnetic method
to first purify bacterial cells from infected macrophages.
The protocol was assessed by visualising the protein
extracts separated by SDS-PAGE. We tested three
different antibodies against lipopolysaccharide, capsular
polysaccharide or against B. pseudomallei cells, each
conjugated separately onto magnetic beads. Using
Fig. 1 Intracellular survival of Burkholderia strains in mouse macrophages. J774A.1 mouse macrophages were exposed to B. thailandensis strain
E555 at an MOI of 10 for 2 h. Following removal of the extracellular bacteria, infected macrophage cells were incubated with kanamycin (1 mg/ml
in the first 2 h and 0.25 mg/ml afterwards) for 1, 2, 4 and 6 h and the mean numbers (with standard errors of the mean) of intracellular bacteria
were determined. B. thailandensis strain E264 and B. pseudomallei strain K96243 values were adapted from Wand et al. [39]. There was no
statistically significant difference between the growth rate of B. thailandensis strain E555 and B. thailandensis strain E264, or between the growth
rate of B. thailandensis strain E555 and B. pseudomallei strain K96243 at any time point (p > 0.05). In contrast, the difference between the growth
rate of B. pseudomallei strain K96243 and B. thailandensis strain E264 was significant: p < 0.001 at 4 h, 6 h and 8 h post-infection, (indicated by ***)
Fig. 2 Validation of RNASeq data by RT-qPCR. RNASeq (green) and RT-qPCR (blue) data at 6 h post-infection in macrophages. Tested genes: [i] 3
genes (Fig|869,728.6.peg.5909*, 6274, 1473) with significantly increased, [ii] 4 genes (Fig|869,728.6.peg.4093*, 5186, 1728, 355) with significantly
decreased and [iii] 2 genes (Fig|869,728.6.peg.5948*, 731) without significantly increased level of expression during macrophage infection (a
known virulence factor* was included in each group). B. pseudomallei homologs of these genes are shown in brackets. Internal control: 23S rRNA.
Expression data is detailed in Additional file 4: Table S2. Horizontal lines show 2-fold change in expression cut-off. Asterisks on the graph indicate
statistical significance
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antibodies against capsular polysaccharide, with an incu-
bation time of 25 min at 4 °C, was the most efficient way
of recovering bacteria from macrophage lysates (data not
shown). Bacterial proteins were then identified by mass
spectrometry (Additional file 6: Table S4). We detected
lower numbers of proteins than corresponding gene
transcripts. For over 90% of the proteins we identified
the corresponding mRNA transcripts but conversely we
could not detect the proteins corresponding to the ma-
jority of the transcripts (Fig. 4). These transcripts were
not close to the limits of detection, suggesting that the
inability to detect the corresponding protein was not
linked to low levels of gene expression (Additional file 1:
Figures S2 and S3). In contrast to the transcriptome
data, not all of the proteins encoded by the wcb operon
were found in the proteome; we detected 12 in broth
grown bacteria and 7 in bacteria isolated from macro-
phages (Additional file 7: Table S5.F).
Compared with transcriptome mapping, our prote-
omic analysis revealed the over-representation of cyto-
plasmic proteins. In contrast, proteins of unknown
location were under-represented compared with tran-
scriptome data sets (Fig. 5), possibly reflecting the limi-
tations of pSORTb in predicting exported proteins [47],
which would be difficult to detect in our proteome
samples.
Intracellular metabolism
We investigated which cellular processes are required
and which are dispensable in bacteria during infection of
macrophages. We found up-regulation, of several fatty
acid biosynthetic enzymes both in the 6 h transcriptome
and in the 6 h proteome. Genes encoding proteins with
roles in the valine, leucine and isoleucine biosynthetic
and degradation pathways were also up-regulated at 6 h
post-infection. In addition, four (argT, hisM, hisQ, hisP)
out of five components of a lysine, arginine, ornithine
and histidine ABC-type transporter and a branched
chain amino acid transporter (livK, livH, livM, livG, livF)
were up-regulated 6 h after infection. We found
down-regulation of a number of genes involved in
nitrogen metabolism (metabolic enzymes and two-com-
ponent systems). Linked to this pathway, glutamate me-
tabolism was down-regulated. Finally our findings that
cysteine and methionine metabolism were downregu-
lated in bacteria isolated from macrophages suggests
that these pathways are dispensable during infection.
Fig. 3 Venn diagram of the transcriptional and translational landscapes of B. thailandensis strain E555 grown in vitro in LB broth and in
macrophages. a Transcriptome. b Proteome. Figures in brackets indicate numbers of known virulence factors
Fig. 4 Correlation between the transcriptional and translational landscapes of B. thailandensis strain E555 grown in vitro in LB broth or in
macrophages. Venn diagram of the transcriptome and the proteome of B. thailandensis strain E555 (a) during in vitro (broth) growth or (b) during
in vivo (macrophage) growth. Figures in brackets indicate the numbers of known virulence factors
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Comparison of the significantly regulated transcriptome
and proteome
We next identified genes and proteins that were signifi-
cantly (p < 0.05) up- or down-regulated at least two-fold
in bacteria isolated from macrophages, compared with
broth-cultured bacteria. We found that 11% of genes
(265 up-regulated and 438 down-regulated) were differ-
entially regulated at 5 h post-infection (Additional file 7:
Table S5), and 15% of genes (396 up-regulated and 583
down-regulated) were differentially regulated at 6 h
post-infection (Additional file 7: Table S5 and Additional
file 1: Figure S4.A). A total of 242 genes were
up-regulated at both 5 h and 6 h post-infection. 23 genes
were up-regulated only at 5 h post-infection and 154
genes were up-regulated only at 6 h post-infection.
Among the 23 genes, 6 were known virulence factors of
which 5 are components of the T3SS-3. Despite the
larger number of up-regulated genes, only an additional
10 genes are known virulence factors of the 154 genes
specific for 6 h post-infection (Additional file 7: Table
S5.D). For our subsequent studies we used transcript
data at 6 h post-infection.
In parallel, the proteomic landscape was investigated.
We applied the same statistical criteria as with the
transcriptomic data and identified 109 up-regulated and
364 down-regulated proteins 6 h post-infection
(Additional file 7: Table S5 and Additional file 1: Figure
S4.B). The number of up- or down-regulated proteins was
smaller than the number of up- or down-regulated genes
(Fig. 6). At 6 h post-infection we found 45% overlap
between significantly up-regulated proteins and genes and
34% overlap between significantly down-regulated pro-
teins and genes (Fig. 6). We found one up-regulated pro-
tein but with decreased corresponding mRNA, and 16
genes with decreased protein levels but with increased
corresponding mRNA levels (Additional file 7: Table S5).
The groups which showed the greatest degree of
enrichment in bacteria isolated from macrophages were
genes encoding proteins involved in translation, and proteins
involved in post-translational modification functions (Fig. 6
a). Proteins associated with amino acid transport and
metabolism, and energy production were over-represented in
the significantly down-regulated proteome but not in the
significantly down-regulated transcriptome (Fig. 7 b).
A C
B D
Fig. 5 Distribution of the cellular localisation of B. thailandensis strain E555 transcripts and proteins detected in culture and in infected
macrophages. a Bacterial transcripts detected during in vitro growth in culture. b Bacterial transcripts detected 6 h after infection of
macrophages. c Bacterial proteins detected during in vitro growth in culture. d Bacterial proteins detected 6 h after infection of macrophages
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Virulence factors
We compiled a list of 326 genes encoding virulence fac-
tors of B. pseudomallei which had been identified from
previous experimental studies (Additional file 2: Supple-
mentary References, Additional file 8: Table S6.A). Of
these we found 267 in both B. thailandensis strain E555
and strain E264, 17 only in B. thailandensis strain E555
and 19 only in B. thailandensis strain E264. The
remaining 23 virulence-associated factors were not
found in either B. thailandensis strain (Additional file 8:
Fig. 6 Comparison of the significantly regulated genes and proteins during macrophage infection. a Over-expressed genes and proteins.
b Repressed genes and proteins. Figures in brackets indicate the numbers of known virulence factors
A
B
Fig. 7 Functional classification by COG designation of B. thailandensis genes and proteins significantly regulated during macrophage infection. Bars
indicate percentages of genes or proteins relative to the total number genes and proteins significantly up-regulated (a) or down-regulated (b)
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Table S6). Of the 17 candidate virulence-associated fac-
tors found in both B. thailandensis strain E555 and B.
pseudomallei but not in B. thailandensis strain E264, 9
are implicated in capsule biosynthesis, 6 genes encoded
hypothetical proteins, 1 encoded a cell surface protein
and 1 a non-ribosomal peptide synthetase. Of the 23
virulence-associated factors found only in B. pseudomal-
lei strain K96243, 16 are hypothetical proteins or have
either unknown or predicted function, 6 are predicted to
be involved in transport, metabolism or catabolism of
amino acids, lipids or secondary metabolites, and 1 is
predicted to have a role in intracellular trafficking and
secretion. These proteins might merit further attention
as potential virulence determinants of B. pseudomallei.
All or most of the genes in T6SS-1, T6SS-2, T6SS-3,
T6SS-5 and T6SS-6 are present in the genome of the B.
thailandensis strain E555 but the T6SS-4 locus is
missing (only two genes, the homologs of BPSS0166 and
BPSS0185, are present).
In bacteria isolated from macrophages at 6 h post-in-
fection expression of 284 of the virulence associated genes
and 102 of the virulence associated proteins were detected
(Fig. 4 b). Most (97%) of the virulence-associated factors
detected in the proteome were also detected in the tran-
scriptome (Fig. 4 b). Of these, 47 genes and 16 pro-
teins were up-regulated compared to broth grown
bacteria (Fig. 6 a) and some virulence-associated
factors were down-regulated (Fig. 6 b).
We found that 14 (56%) of the 25 most highly
up-regulated genes in B. thailandensis isolated from
macrophages are known virulence factors of B. pseudo-
mallei (Table 1). 11 of these genes encode components
of the type VI secretion system-1 (T6SS-1) (Fig. 8 b) and
the remaining genes encode BsaN, BimA and BprB
which are associated with virulence [13, 48–50]. We also
found that 10 of the 30 type III secretion system-3
(T3SS-3) genes were upregulated at 6 h post-infection
(Fig. 8 a, Additional file 5: Table S3.D and Additional
file 7: Table S5). One of the T3SS-3 genes (bsaN) was
in the 25 most up-regulated genes (Table 1). RT-PCR
data validated the up-regulation of bsaR, a component
of the T3SS-3, and tssD-5 (hcp1), a component of the
T6SS-1 (Fig. 2).
Four genes involved in iron acquisition were up-regulated
in B. thailandensis strain E555 isolated from macrophages
(Table 1; Bt E555 fig|869,728.6.peg.2756, 3100, 6277 and
3095; in B. pseudomallei BPSS0244, BPSL1779, BPSS0362
and BPSL1783, respectively) highlighting the importance of
iron acquisition during infection.
The known importance of lipopolysaccharide [51]
during infection by B. pseudomallei was mirrored by our
finding of increased expression of the rfbA-rfbB
lipopolysaccharide ABC-transporter genes and increased
expression of lipopolysaccharide biosynthetic genes and
proteins in B. thailandensis strain E555 within macro-
phages. We also found up-regulation of B. thailandensis
strain E555 fig|869,728.6.peg.5896 (BPSS1490 in B.
pseudomallei) which encodes a peptidoglycan biosyn-
thetic enzyme (Table 1). Of the capsule genes only wcbA
and wcbK were significantly up-regulated (in the 6 h
transcriptome and in the 6 h proteome, respectively).
The role of the SyrP-like protein Bt E555 fig|869,728.6.-
peg.3093 (BPSL1785 in B. pseudomallei) in virulence has
not been tested experimentally in B. pseudomallei but
there is evidence that it plays a role in the virulence of
Pseudomonas syringae through the control of syringomy-
cin production [52] and this gene was highly up-regulated
in B. thailandensis strain E555 isolated from macrophages
(Table 1).
Using our data we investigated whether up-regulated
genes or up-regulated proteins were more likely to be
virulence-associated factors. Significantly up-regulated
genes identified 16% of the known virulence-associated
factors, whilst significantly up-regulated proteins re-
vealed only 5% (Table 2 and Additional file 9: Table S7).
However, the proteome analysis identified virulence
factors with higher degree of confidence than the tran-
scriptome analysis (14.7% versus 11.9%). Combining the
significantly up-regulated gene and protein datasets did
not significantly improve the predictive power. But
looking at the genes common in both the significantly
up-regulated transcriptome and the significantly up-reg-
ulated proteome increased the likelihood of detection of
virulence factors (22%; Table 2). In comparison, the like-
lihood of randomly identifying a virulence-associated
factor from the genome is approximately 5%.
Some proteins, such as those which are membrane
located or secreted, are difficult to recover while the
corresponding transcripts are not subject to these
constraints. Since the most likely cellular locations of
virulence factors are at the cell surface and in the extra-
cellular milieu, this might limit the utility of proteomics
for the identification of virulence factors. However,
extracellular, outer membrane and periplasmic proteins
were found in similar proportions in the proteomes and
in the corresponding transcriptomes. Nevertheless, all
proteins are initially translated in the cytoplasm allowing
their detection in this cellular compartment. Therefore,
proteome analysis might also provide confident data for
identification of classic virulence candidates, especially
because the majority of cellular processes occur at
protein level and not at transcript level.
Discussion
Central to this study is the proposition that B. thailan-
densis is a surrogate for understanding the interactions
of B. pseudomallei with host cells. Most previous studies
have used B. thailandensis strain E264 for these studies,
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but our work reveals that unlike B. thailandensis strain
E264, B. thailandensis strain E555 grows at similar rate
to B. pseudomallei in macrophages. A previous report
showed that a B. pseudomallei mutant lacking capsular
polysaccharide showed no difference in intracellular
growth rate compared to the wild type [53]. Therefore
the similar behaviour of B. thailandensis strain E555 to
B. pseudomallei in host cells is unlikely to be due simply
to the presence of the similar capsule in these different
bacteria. Consistent with this we find that the overall
genetic makeup of B. thailandensis strain E555 is more
similar to that of B. pseudomallei strain K96243 than to
the overall genetic makeup of B. thailandensis strain
E264.
In this study we also compared the relative utilities of
transcriptomic or proteomic approaches to identify
Fig. 8 Expression of the T3SS and T6SS-1 genes in the bacterial transcriptome during infection of macrophages. Up-regulation of the (a) T3SS and the
(b) T6SS-1 genes. Homologs of the T3SS and T6SS-1 genes in B. pseudomallei are shown in brackets. Green circles: data for 5 h post-infection, green
rectangles: data for 6 h post-infection, filled shapes represent significant up-regulation. Data was taken from Additional file 7: Table S5
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genes which are differentially regulated after infection.
Of the 6508 total genes encoded by the B. thailandensis
strain E555 genome, RNA-seq analysis detected expres-
sion of approximately 88% of the genes during growth in
broth or in macrophages. In parallel mass spectrometry
identified 42% of the predicted proteins. Similar findings
have been reported in other bacteria [54–57]. Our
finding that the transcriptome and proteome did not
precisely mirror each other is not unexpected. In an
Escherichia coli single-cell study [57] the correlation
coefficient between mRNA and protein levels of the
same gene averaged zero for the genes tested. Although
according to the central dogma of molecular biology that
transcription and translation are tightly linked in pro-
karyotes [58], the lack of correlation between mRNA
and the encoded protein has been attributed to differ-
ences in the stability of these molecules [57] and in
translation efficiency. Translation efficiency has a large
impact on transcript-protein correlation. For example
transcripts that have weak Shine-Dalgarno sequences are
translated less efficiently [59, 60]. Secondary structure of
the mRNA [61] and codon bias (large codon bias corre-
lates with highly expressed genes [62, 63] and proteins
[64]) also have an influence on translation efficiency.
Untranslated RNA molecules are also considered to be
responsible for the differences between the transcrip-
tomic and the proteomic results. However, the most
important factor responsible for low correlations be-
tween mRNA and protein expressions is the long
half-life of proteins relative to mRNAs. Transcripts are
instantaneous messengers that are degraded in 3 to 8
min [65], while proteins are accumulated products with
a typical half-life of ∼20 h in E. coli [66, 67]. Finally, the
reduced ability to recover some membrane-located or
secreted proteins would limit the ability to detect them.
These differences found between the transcriptomic and
the proteomic data highlight the value of profiling both
the transcriptome and the proteome.
Our comparison of the transcriptomes and proteomes
of B. thailandensis strain E555 showed that most of the
detected proteins were also present in the corresponding
transcriptomes. We looked for transcripts and proteins
that are significantly up-regulated during infection and
found that an analysis of the transcriptome revealed
more virulence-associated factors than an analysis of the
proteome. However, although the proteome data
revealed fewer virulence factors, they were identified
with a higher degree of confidence. We found some ex-
amples of opposite patterns of gene and protein expres-
sion after infection (Additional file 7: Table S5). This
raises the question of which method to use identifying
candidate virulence factors. Among these genes we
detected 1 virulence-associated factor (Fig|869,728.6.-
peg.5292) which was significantly up-regulated in the
transcriptome but down-regulated in the proteome.
Both analyses generated false negative results. For
example, deletion of the treA gene (BPSS0671) results in
reduced intracellular survival of B. pseudomallei [68]
but, compared to broth grown bacteria expression of the
trehalase A gene in B. thailandensis strain E555
(Fig|869,728.6.peg.4715) was reduced during macro-
phage infection and the protein was not detected in
culture or in macrophages. We also found numbers of
other known virulence factors in the significantly
down-regulated groups (Additional file 7: Table S5). This
may reflect the different roles of virulence factors in
different cell types or different hosts or at different
stages of infection.
In summary, we combined a transcriptomic and prote-
omic approach to elucidate the changes involved in the
adaptation of B. thailandensis strain E555 to macro-
phage cells. The differences found between the tran-
scriptomic and the proteomic data suggested various
post-transcriptional mechanisms and the complexity of
the bacterial adaptation.
Conclusions
In contrast with B. thailandensis strain E264, which has
been used widely as a surrogate model for B. pseudomal-
lei, we show that the pattern of growth of B. thailanden-
sis strain E555 in macrophages more closely mirrors that
of B. pseudomallei. Using this infection model we have
shown that many of the known virulence factors of B.
pseudomallei can be identified as genes or proteins
Table 2 Summary of bacterial virulence factors detected in the transcriptome and in the proteome during infection of
macrophages
Groups Description Total number
of genes
Number of
virulence factors
Virulence factors in
proportion of the total known
virulence factors in
B. thailandensis E555 (302)
proportion of the genes
detected in the group
(column 3)
A Significantly up-regulated in the transcriptome 396 47 15.6% 11.9%
B Significantly up-regulated in the proteome 109 16 5.3% 14.7%
A + B All genes in Groups A and B 456 52 17.2% 11.4%
A = B Common genes in Groups A and B 49 11 3.6% 22.4%
See the lists of genes in each group in the Additional file 9: Table S7
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whose expression is elevated on the infection of macro-
phages. This finding further confirms the utility of B.
thailandensis strain E555 as a surrogate for B. pseudo-
mallei. The identification of up-regulated genes provided
a more comprehensive identification of virulence factors
than the identification of up-regulated proteins.
Methods
Bacterial strain and cell culture growth conditions
B. thailandensis strain E555 (gift from Patrick Tan, Gen-
ome Institute of Singapore) was grown on Luria-Bertani
(LB) agar or in LB broth (200 rpm) at 37 °C. J774A.1
mouse macrophage cells (European Collection of Cell
Cultures, ECACC; Catalog No. 91051511) were main-
tained at 37 °C under 5% CO2 atmosphere in DMEM
(with 4.5 g/l Glucose, 4.0 mM L-Glutamine and Sodium
Pyruvate; Gibco 11,995,073) supplemented with 10%
heat inactivated fetal bovine serum (FBS Gold; PAA
A15–751).
Macrophage infection model
For infection assays, 1.5 × 105 cells/well in 24-well cell
culture plates or 6 × 106 cells/T75 flask (approximately
7.9 × 104 cells/cm2) were seeded and an overnight
culture of bacteria was diluted to 1.5 × 106 cells/ml or to
6 × 107 cells/10 ml in Leibovitz L-15 Media (with 2.05
mML-Glutamine; Gibco 21,083,027), respectively.
J774A.1 monolayers were washed once with L-15
medium before addition of bacteria at a multiplicity of
infection of 10 (1 ml/well or 10 ml/T75 flask). Murine
macrophages with the bacterial cells were incubated at
37 °C for 2 h to allow bacterial internalisation to occur.
Extracellular bacteria were removed by washing the
macrophage cells three times with warm PBS (Gibco
10,010,023). Fresh media containing kanamycin (1 mg/
ml, which was replaced with 0.25 mg/ml kanamycin after
2 h of incubation) was then added to each well or flask
to suppress the growth of extracellular bacteria. Infected
cells were incubated in the presence of kanamycin at 37
°C until washed three times with PBS at appropriate
time points. To determine the number of intracellular
bacteria, macrophages were lysed in 0.1% Triton X-100
(Sigma-Aldrich T8787) in PBS for 5 mins, the lysis
mixture was serially diluted and plated out on LB agar
plates, which were then incubated overnight at 37 °C to
allow bacteria to grow. Unless otherwise stated, all infec-
tions were performed as three independent experiments,
each with three technical replicates. Macrophages
infected in T75 flasks were processed for transcriptome
and proteome analysis as detailed below.
Genome sequencing and assembly
DNA were prepared for sequencing using a Promega
Wizzard Genomic DNA Purification kit according to the
manufacturer’s instructions. Sequencing was performed
at the University of Exeter Sequencing Facility using an
‘Illumina HiSeq 2500 System’ benchtop sequencing in-
strument (read length: 100 bp, read type: paired end).
Illumina adapters were removed and sequences quality
trimmed using ea-utils [69]. SPAdes [70] was used to
perform a de-novo assembly of the samples. This Whole
Genome Shotgun project has been deposited at DDBJ/
ENA/GenBank under the accession SJET00000000.
Bacterial RNA extraction, sequencing and reverse
transcription quantitative real-time PCR (RT-qPCR) for
transcriptional studies
Total RNA was extracted from infected macrophages
(internalised CFU per replicate approximately 1.5 × 107
and 2 × 107 at 5 and 6 h, respectively) and from bacterial
cultures, and the RNA integrity number (RIN) was
determined. RIN was more than 9 with all the extracts
indicating no evidence of RNA degradation. After the
final washing step at 5 or 6-h post-infection (2-h infec-
tion + 3 or 4-h kanamycin treatment), 2 ml TRIzol®
Reagent (Invitrogen 15,596,026) was added to the flasks
to lyse both the macrophage and bacterial cells. Cell
lysates were stored at − 80 °C until further processing.
When thawed, total RNA (total eukaryotic and total pro-
karyotic RNA) was extracted using the Direct-zol™ RNA
MiniPrep Kit (Zymo Research R2052). Contaminating
DNA was digested by DNAse I treatment (Ambion
AM2222) which was confirmed by reverse transcriptase
PCR (Qiagen OneStep RT-PCR Kit 210,212) using
primers glt1-F (5` CGCACCATGACATCTATTCG 3`)
vs glt1-R (5` ACCGGATTGACGTTCTTCAG 3`).
DNA-free RNA was treated with the TruSeq RNA
Library Preparation Kit v2 (Illumina RS-122-2001) and
the Ribo-Zero Gold rRNA Removal Kit (Epidemiology)
(Illumina MRZE724). Eukaryotic mRNA was first re-
moved using poly-A selection, the remaining RNA was
then enriched for bacterial mRNA by depleting both the
bacterial and macrophage rRNA and the RNA-seq
libraries were prepared to the guidelines of the manufac-
turer. Control bacterial mRNA was obtained from the
overnight broth cultures of bacteria which were used to
infect macrophage cells. RNA from broth culture was
isolated as described above (including the poly-A deple-
tion step). RNA was isolated from 3 separate assays
(biological replicates) from both infected macrophages
and control bacteria. RNA-seq libraries were created
using the Illumina TruSeq Stranded mRNA Library Prep
Kit according to the manufacturer’s protocol. The con-
centration, quality and integrity of all RNA and DNA
samples were analysed using the Agilent 2100 Bioanaly-
ser. Sequencing was performed at the University of
Exeter Sequencing Facility using an ‘Illumina MiSeq
System’ benchtop sequencing instrument (read length:
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75 bp, read type: paired end). Reads from RNASeq were
mapped to the B. thailandensis strain E555 genome as-
sembly using Tophat [71]. Cufflinks [72] was used for
transcript assembly of individual samples. All assemblies
were merged to create a reference transcript, which was
used to calculate gene counts with HTSeq [73]. DESeq
[74] was then used to find differentially expressed genes.
Transcripts with a p-value< 0.05 and more than 2-fold
differential expression were considered significantly
expressed.
The preparation of cDNA from total RNA extracted
from culture and infected macrophages was carried out
using the Superscript III Reverse Transcriptase Synthesis
System (Invitrogen 18,080,051) with random hexamers
according to the manufacturer’s recommendations.
RT-qPCR was performed with primers annealing to in-
ternal regions of the target genes (Additional file 10:
Table S8) using Platinum® SYBR® Green qPCR
SuperMix-UDG according to the manufacturer’s manual
(Invitrogen 11,733,038). For the adjustment of cDNA
amounts, the housekeeping gene 23S rRNA [75] was
used as internal standard.
Bacterial protein extraction and mass spectrometric
analysis for proteomic studies
In contrast to the RNA, prokaryotic and eukaryotic
proteins are indistinguishable. Therefore, intact bacterial
cells were first extracted from infected macrophages and
bacterial proteins were then isolated from the bacterial
cells. Macrophages were infected as described above
using the same conditions as used for the 6 h transcrip-
tome samples (i.e. internalised CFU per replicate ap-
proximately 2 × 107 at 6 h post-infection). Following the
final washing step at 6-h post-infection (2-h infection +
4-h kanamycin treatment) infected macrophages in T75
flasks were lysed in 0.1% Triton X-100 in PBS for 5 mins
to release the intracellular bacteria and whole bacterial
cells were isolated using a modified immunomagnetic
separation technique described previously by Twine et
al. [76]. Briefly, Dynabeads® M-270 Epoxy (Life Tech-
nologies 14311D) were covalently attached to goat
α-mouse IgG (H + L) secondary antibodies (Invitrogen
A16068) as per the manufacturer’s instructions (20 μg of
antibodies per 1 mg of magnetic beads were used) and
magnetic beads coated with secondary antibodies were
labelled with mouse α-capsule primary antibodies (CPS
4V1H12 [12]) (17.5 μg of α-CPS antibodies per 1 mg of
bead – secondary antibody complexes), which recognise
surface antigens of B. thailandensis strain E555 cells.
Magnetic bead – α-mouse – α-CPS complexes were
then used to purify the bacteria. 1 mg of beads coated
with both antibodies was mixed with macrophage cell
lysate per T75 flask and incubated for 25 min with con-
stant agitation (35 rpm) at 4 °C to capture the bacterial
cells. The beads-bacteria complexes were separated from
the cell debris on a magnetic stand, washed, and imme-
diately re-suspended in BugBuster® Protein Extraction
Reagent (Novagen 70,584) to lyse the bacterial cells and
release the proteins. Bacterial purification was completed
in about 45 min. Control extracts included bacterial
proteins isolated by BugBuster® Protein Extraction
Reagent from the overnight broth cultures of bacteria
which were used to infect macrophage cells.
Mass spectrometric analysis of protein samples
isolated from 3 biological replicates of both infected
macrophages and bacterial cultures was done by the
University of Bristol Proteomics Facility. Proteomics was
performed as described previously using an UltiMate™
3000 nano HPLC system in line with an LTQ-Orbitrap
Velos mass spectrometer (Thermo Scientific) [77]. The
raw data files were processed and quantified using Prote-
ome Discoverer software v1.2 (Thermo Scientific) and
searched against B. thailandensis strain E555 RAST
ORFs using the SEQUEST algorithm. The reverse
database search option was enabled and all peptide data
was filtered to satisfy false discovery rate (FDR) of 5%.
Abundance of each protein in each sample was calcu-
lated using the average area measurements of the three
most abundant peptides matching to each protein (Top3
method) [78]. This value was then expressed in the
fraction of the signal derived from the 100 most
abundant proteins detected in each sample which was
then compared for each protein in LB broth and macro-
phages. Statistical significance of the fold change differ-
ence was calculated using R with q-values reported after
5% FDR correction. All proteins with a q-value< 0.05
and more than 2-fold change difference were considered
significantly regulated.
Online and bioinformatic tools
Genome sequence of B. thailandensis strain E555 was
annotated using the web-based RAST server (Rapid
Annotation using Subsystem Technology) [44]. Cellular
localisation of the predicted proteins encoded in the B.
thailandensis strain E555 genome was predicted using
PSORTb 3.0 [79] (Additional file 3: Table S1.D). Protein
homologs in B. pseudomallei strain K96243, B. thailan-
densis strain E555 and B. thailandensis strain E264 were
identified by blast search. Proteins were considered
homologs if they met the following criteria: e value
≤0.000001 and (i) sequence identity > 30% if alignment
length/query length > 90% [80], (ii) sequence identity >
40% if alignment length/query length between 70 and
90%, (iii) sequence identity > 55% if alignment length/
query length between 50 and 70% (Additional file 3:
Table S1.C). Correlation coefficients between the
samples were calculated using the formula built-in the
Microsoft Excel Software. B. thailandensis strain E555
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genes were classified into functional categories based on
clusters of orthologous gene (COG) designations; func-
tional classes of B. thailandensis genes and proteins were
determined based on the categorisation of their homo-
logs in B. pseudomallei (Sheet C of Additional file 4:
Table S2 in reference [81], Additional file 3: Table S1 D).
Statistical analysis of growth curves was performed using
Graph Pad Prism 5.03 software One-way ANOVA
Kruskal-Wallis test with Dunns post test. DESeq [74]
was used to determine fold change and the p value of
differential expression in the RNASeq data. Statistical
significance (q value) of the fold change difference in the
proteome was calculated using R. To identify pathways
that are up- or down-regulated during infection we used
Keg Array 1.2.4a software which maps the genes/pro-
teins to KEGG pathways. Up-regulation or down-regula-
tion of genes/proteins with at least 1.5-fold increase or
decrease in expression difference was considered to be
necessary or dispensable respectively during macrophage
infection.
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